Michael W. Dunne - 01 Apr 2023 Form 4/A - Amendment Insider Report for Iterum Therapeutics plc (ITRM)

Role
Director
Signature
/s/ Michael W. Dunne
Issuer symbol
ITRM
Transactions as of
01 Apr 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
05 Jun 2023, 08:00:07 UTC
Date Of Original Report
03 Apr 2023
Previous filing
04 Jan 2023
Next filing
15 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITRM Ordinary Shares Options Exercise $0 +1,299 +3.6% $0.000000 37,635 01 Apr 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
F2 This amendment is being filed solely to correct an error in the Amount of Securities Beneficially Owned Following Reported Transaction in the original Form 4, as filed on April 3, 2023. The Amount of Securities Beneficially Owned Following Reported Transaction on April 1, 2023, which were reported as 37,636, should have been reported as 37,635.